Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Carcinogenesis|January 31, 2019
The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activityJae-Hwi Jang, Florian Janker, Ingrid De Meester, et al.
Clinical & Experimental Metastasis|August 3, 2015
Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in miceJae-Hwi Jang, Lesley Baerts, Yannick Waumans, et al.
Clinical Therapeutics|April 29, 2021
Effect of Statin Therapy on the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients With Hyperlipidemia: A Proof-of-concept Observational StudyKaren Claesen, Joachim C Mertens, Shahir Basir, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Synthesis and dipeptidyl peptidase inhibition of N-(4-substituted-2,4-diaminobutanoyl)piperidinesAnna Soroka, Pieter Van der Veken, Ingrid De Meester, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 13, 2016
Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptinJae-Hwi Jang, Yoshito Yamada, Florian Janker, et al.
Molecules (Basel, Switzerland)|July 2, 2021
In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA<sup>5</sup>.SA.FAPi and DOTA.SA.FAPiEuy Sung Moon, Yentl Van Rymenant, Sandeep Battan, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Development of potent and selective dipeptidyl peptidase II inhibitorsKristel Senten, Pieter Van der Veken, Gunther Bal, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 30, 2007
Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemiaWei Zhai, Markus Cardell, Ingrid De Meester, et al.
Transplantation|August 22, 2009
The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejectionWolfgang Jungraithmayr, Birgit Oberreiter, Ingrid De Meester, et al.
Archives of Pathology & Laboratory Medicine|April 3, 2018
Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection MethodsKelly A Schats, Emily A Van Vré, Carolien Boeckx, et al.
Pageof 13